Duchenne muscular dystrophy (DMD) is marked by pathogenic variants in the DMD gene,
leading to reduced or absent dystrophin translation, muscle fiber destruction, loss of …

Deflazacort and prednisone/prednisolone are the current standard of care for patients with
Duchenne muscular dystrophy (DMD) based on evidence that they improve muscle strength …

Dry eye disease is a multifactorial pathology compromising the quality of life of patients,
resulting in significant damage of the ocular surface and discomfort. The current …

Duchenne muscular dystrophy (DMD) is a relatively widespread genetic disease which
develops as a result of a mutation in the gene DMD encoding dystrophin. In this review …

Duchenne muscular dystrophy (DMD) is caused by X-linked inherited or de novo DMD gene
mutations predominantly affecting males who develop early-onset muscle degeneration …

Background: Evidence on the long-term efficacy of steroids in Duchenne muscular dystrophy
(DMD) after loss of ambulation is limited. Objective: Characterize and compare disease …

Aim: To examine benefits of corticosteroids for Duchenne muscular dystrophy (DMD) by age
and disease progression. Methods: Data from daily steroid users (placebo-treated) were …

Duchenne muscular dystrophy (DMD) is a lethal, muscle-wasting, genetic disease that is
greatly amplified by an immune response to the diseased muscles. The mdx mouse model …

Background: The dystrophin gene has multiple isoforms: full-length dystrophin (dp427) is
principally known for its expression in skeletal and cardiac muscle, but is also expressed in …

Dry eye (DED) is a prevalent disease with immune-mediated inflammation as the principal
pathophysiological etiology. Olive pomace, the major by-product of the olive oil industry, is …